Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Correction to: Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 May 24;9(6):622. doi: 10.1038/s41419-018-0638-2.

2.

Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 Mar 2;9(3):359. doi: 10.1038/s41419-018-0394-3. Erratum in: Cell Death Dis. 2018 May 24;9(6):622.

3.

MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage.

Klei LR, Hu D, Panek R, Alfano DN, Bridwell RE, Bailey KM, Oravecz-Wilson KI, Concel VJ, Hess EM, Van Beek M, Delekta PC, Gu S, Watkins SC, Ting AT, Gough PJ, Foley KP, Bertin J, McAllister-Lucas LM, Lucas PC.

Cell Rep. 2016 Sep 27;17(1):221-232. doi: 10.1016/j.celrep.2016.08.080.

4.

More to Life than NF-κB in TNFR1 Signaling.

Ting AT, Bertrand MJM.

Trends Immunol. 2016 Aug;37(8):535-545. doi: 10.1016/j.it.2016.06.002. Epub 2016 Jul 13. Review.

5.

CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.

Legarda D, Justus SJ, Ang RL, Rikhi N, Li W, Moran TM, Zhang J, Mizoguchi E, Zelic M, Kelliher MA, Blander JM, Ting AT.

Cell Rep. 2016 Jun 14;15(11):2449-61. doi: 10.1016/j.celrep.2016.05.032. Epub 2016 Jun 2.

6.

Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1.

Justus SJ, Ting AT.

Immunol Rev. 2015 Jul;266(1):145-60. doi: 10.1111/imr.12304. Review.

PMID:
26085213
7.

Differential induction of plasma cells by isoforms of human TACI.

Garcia-Carmona Y, Cols M, Ting AT, Radigan L, Yuk FJ, Zhang L, Cerutti A, Cunningham-Rundles C.

Blood. 2015 Mar 12;125(11):1749-58. doi: 10.1182/blood-2014-05-575845. Epub 2015 Jan 28.

8.

Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Manganaro L, Pache L, Herrmann T, Marlett J, Hwang Y, Murry J, Miorin L, Ting AT, König R, García-Sastre A, Bushman FD, Chanda SK, Young JA, Fernandez-Sesma A, Simon V.

J Virol. 2014 Jul;88(13):7528-40. doi: 10.1128/JVI.00239-14. Epub 2014 Apr 23.

9.

T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation.

Jianjun Yang, Zhang R, Lu G, Shen Y, Peng L, Zhu C, Cui M, Wang W, Arnaboldi P, Tang M, Gupta M, Qi CF, Jayaraman P, Zhu H, Jiang B, Chen SH, He JC, Ting AT, Zhou MM, Kuchroo VK, Morse HC 3rd, Ozato K, Sikora AG, Xiong H.

J Exp Med. 2013 Jul 1;210(7):1447-62.

10.

The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.

Rosebeck S, Rehman AO, Apel IJ, Kohrt D, Appert A, O'Donnell MA, Ting AT, Du MQ, Baens M, Lucas PC, McAllister-Lucas LM.

Oncogene. 2014 May 8;33(19):2520-30. doi: 10.1038/onc.2013.195. Epub 2013 Jun 17.

11.

Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation.

Blackwell K, Zhang L, Workman LM, Ting AT, Iwai K, Habelhah H.

Mol Cell Biol. 2013 May;33(10):1901-15. doi: 10.1128/MCB.01416-12. Epub 2013 Mar 4.

12.

NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1.

O'Donnell MA, Hase H, Legarda D, Ting AT.

PLoS One. 2012;7(7):e41238. doi: 10.1371/journal.pone.0041238. Epub 2012 Jul 26.

13.

NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death.

O'Donnell MA, Ting AT.

Immunol Res. 2012 Dec;54(1-3):214-26. doi: 10.1007/s12026-012-8321-7. Review.

PMID:
22477525
14.

Caspase 8 inhibits programmed necrosis by processing CYLD.

O'Donnell MA, Perez-Jimenez E, Oberst A, Ng A, Massoumi R, Xavier R, Green DR, Ting AT.

Nat Cell Biol. 2011 Oct 30;13(12):1437-42. doi: 10.1038/ncb2362.

15.

Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.

Lu J, McEachern D, Sun H, Bai L, Peng Y, Qiu S, Miller R, Liao J, Yi H, Liu M, Bellail A, Hao C, Sun SY, Ting AT, Wang S.

Mol Cancer Ther. 2011 May;10(5):902-14. doi: 10.1158/1535-7163.MCT-10-0864. Epub 2011 Mar 3.

16.

RIP1 comes back to life as a cell death regulator in TNFR1 signaling.

O'Donnell MA, Ting AT.

FEBS J. 2011 Apr;278(6):877-87. doi: 10.1111/j.1742-4658.2011.08016.x. Epub 2011 Feb 8.

17.

Chronicles of a death foretold: dual sequential cell death checkpoints in TNF signaling.

O'Donnell MA, Ting AT.

Cell Cycle. 2010 Mar 15;9(6):1065-71. Epub 2010 Mar 15. Review.

18.

NEMO/IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint during TNF signaling.

Legarda-Addison D, Hase H, O'Donnell MA, Ting AT.

Cell Death Differ. 2009 Sep;16(9):1279-88. doi: 10.1038/cdd.2009.41. Epub 2009 Apr 17.

19.

The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.

Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cárdenas WB, Yount JS, Moran TM, Basler CF, Komuro A, Horvath CM, Xavier R, Ting AT.

EMBO Rep. 2008 Sep;9(9):930-6. doi: 10.1038/embor.2008.136. Epub 2008 Jul 18.

20.

Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t.

Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, Li X, Sellati R, Jiang H, Zhang S, Li H, Zhao J, Ting AT, Mayer L, Unkeless JC, Labadia ME, Hodge M, Li J, Xiong H.

Eur J Immunol. 2008 May;38(5):1204-14. doi: 10.1002/eji.200838145.

21.

Teaching resources. Using web-based discussion forums as a model of the peer-review process and a tool for assessment.

Jenkins SL, Iyengar R, Diverse-Pierluissi MA, Chan AM, Devi LA, Sobie EA, Ting AT, Weinstein DC.

Sci Signal. 2008;1(9):tr2.

22.

Inquiry learning. Integrating content detail and critical reasoning by peer review.

Iyengar R, Diverse-Pierluissi MA, Jenkins SL, Chan AM, Devi LA, Sobie EA, Ting AT, Weinstein DC.

Science. 2008 Feb 29;319(5867):1189-90. doi: 10.1126/science.1149875. No abstract available.

23.

Negative regulation of TCR signaling by NF-kappaB2/p100.

Legarda-Addison D, Ting AT.

J Immunol. 2007 Jun 15;178(12):7767-78.

24.

Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.

O'Donnell MA, Legarda-Addison D, Skountzos P, Yeh WC, Ting AT.

Curr Biol. 2007 Mar 6;17(5):418-24. Epub 2007 Feb 15.

25.

PIP(2) regulates the ionic current of P2X receptors and P2X(7) receptor-mediated cell death.

Zhao Q, Yang M, Ting AT, Logothetis DE.

Channels (Austin). 2007 Jan-Feb;1(1):46-55. Epub 2007 Jan 29.

PMID:
19151591
26.
27.
28.

[Study on a new IL-12 inducing gene NAP2].

Yang M, Liu N, Ting AT.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Jul;19(4):403-5. Chinese.

PMID:
15163399
29.
30.
33.

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

Jiang C, Ting AT, Seed B.

Nature. 1998 Jan 1;391(6662):82-6.

PMID:
9422509
34.
35.

Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells.

Ting AT, Dick CJ, Schoon RA, Karnitz LM, Abraham RT, Leibson PJ.

J Biol Chem. 1995 Jul 7;270(27):16415-21.

36.

Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis.

Bonnema JD, Rivlin KA, Ting AT, Schoon RA, Abraham RT, Leibson PJ.

J Immunol. 1994 Mar 1;152(5):2098-104.

PMID:
7907631
37.
38.
39.

Supplemental Content

Support Center